Outsourced Pharma App Notes & Case Studies

  1. The Many Benefits Of Outsourcing Stability 6/2/2026

    Outsourcing stability testing improved efficiency, reduced costs, and enhanced scalability, enabling robust lifecycle support, regulatory compliance, and optimized resource utilization across programs.

  2. In Silico Immunogenicity Assessment For Peptides 8/11/2026

    Predict immunogenic risks in peptides with unnatural amino acids using in silico workflows. High-accuracy simulations predict HLA binding to accelerate safety assessments and regulatory approvals.

  3. Accelerate LNP Manufacturing With Automated Process Development 2/5/2026

    Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.

  4. Supporting An Oncology Company In A Treatment For A Rare Tumor 6/2/2026

    Integrated development enabled efficient RSM synthesis, scale-up, and GMP manufacturing, advancing rare tumor therapies with improved efficiency, quality, and regulatory readiness.

  5. Understanding The EU Regulatory Landscape For Cell And Gene Therapies 4/9/2026

    EU approval for cell and gene therapies isn't just a different process, it's a different playbook. Here's what US manufacturers need to know before they engage.

  6. Cell Retention Technology And Specialized Cell Culture Media 8/11/2025

    Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.

  7. ElevateBio BaseCamp Cleanroom Expansion 7/30/2026

    Expanding active cleanrooms risks environmental stability. A risk-based commissioning strategy protects ongoing production, verifies HVAC performance, and streamlines qualification timelines.

  8. Producing Quality APIs At Scale 5/7/2026

    Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

  9. Cell Culture Media Mixing In A Benchtop Single-Use Mixer 11/13/2025

    Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.

  10. 5 Operational Gaps To Avoid CGT Patient Risks 5/27/2026

    Examine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.